Login / Signup

Lower probability of relapse after myeloablative cord blood transplantation for patients with refractory AML.

Andromachi ScaradavouJaap Jan Boelens
Published in: British journal of haematology (2022)
Keyphrases
  • cord blood
  • allogeneic hematopoietic stem cell transplantation
  • acute myeloid leukemia
  • stem cell transplantation
  • acute lymphoblastic leukemia
  • free survival
  • high dose
  • stem cells
  • mesenchymal stem cells